These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 17950310)

  • 1. Pathogenic mechanisms of pulmonary arterial hypertension.
    Chan SY; Loscalzo J
    J Mol Cell Cardiol; 2008 Jan; 44(1):14-30. PubMed ID: 17950310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of pulmonary hypertension.
    Yildiz P
    Clin Chim Acta; 2009 May; 403(1-2):9-16. PubMed ID: 19361468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular interplay in pulmonary arterial hypertension: implications for new therapies.
    Nogueira-Ferreira R; Ferreira R; Henriques-Coelho T
    Biochim Biophys Acta; 2014 May; 1843(5):885-93. PubMed ID: 24491811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The etiopathogenesis of pulmonary hypertension: inflammation, vascular remodeling].
    Kayikçioğlu M
    Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():5-8. PubMed ID: 20819761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication.
    Guignabert C; Tu L; Girerd B; Ricard N; Huertas A; Montani D; Humbert M
    Chest; 2015 Feb; 147(2):529-537. PubMed ID: 25644906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of Inflammation and Epigenetic Readers in Coronary Artery Remodeling in Patients With Pulmonary Arterial Hypertension.
    Meloche J; Lampron MC; Nadeau V; Maltais M; Potus F; Lambert C; Tremblay E; Vitry G; Breuils-Bonnet S; Boucherat O; Charbonneau E; Provencher S; Paulin R; Bonnet S
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1513-1523. PubMed ID: 28473439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and molecular pathobiology of pulmonary arterial hypertension.
    Humbert M; Morrell NW; Archer SL; Stenmark KR; MacLean MR; Lang IM; Christman BW; Weir EK; Eickelberg O; Voelkel NF; Rabinovitch M
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):13S-24S. PubMed ID: 15194174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Ion Channel Remodeling in Endothelial Dysfunction Induced by Pulmonary Arterial Hypertension.
    Santos-Gomes J; Le Ribeuz H; Brás-Silva C; Antigny F; Adão R
    Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    Leopold JA; Maron BA
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α.
    Dai Z; Li M; Wharton J; Zhu MM; Zhao YY
    Circulation; 2016 Jun; 133(24):2447-58. PubMed ID: 27143681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary arterial hypertension (ascites syndrome) in broilers: a review.
    Wideman RF; Rhoads DD; Erf GF; Anthony NB
    Poult Sci; 2013 Jan; 92(1):64-83. PubMed ID: 23243232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal Mechanisms of Vascular Remodeling in the Development of Pulmonary Arterial Hypertension.
    Li MX; Jiang DQ; Wang Y; Chen QZ; Ma YJ; Yu SS; Wang Y
    J Cardiovasc Pharmacol; 2016 Feb; 67(2):182-90. PubMed ID: 26448276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
    Orriols M; Gomez-Puerto MC; Ten Dijke P
    Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
    Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
    Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Charting the cellular landscape of pulmonary arterial hypertension through single-cell omics.
    Tang B; Vadgama A; Redmann B; Hong J
    Respir Res; 2024 May; 25(1):192. PubMed ID: 38702687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potassium channels in pulmonary arterial hypertension.
    Boucherat O; Chabot S; Antigny F; Perros F; Provencher S; Bonnet S
    Eur Respir J; 2015 Oct; 46(4):1167-77. PubMed ID: 26341985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology and pathobiology of pulmonary hypertension.
    Guignabert C; Dorfmuller P
    Semin Respir Crit Care Med; 2013 Oct; 34(5):551-9. PubMed ID: 24037624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Ablation of PDGF-Dependent Signaling Pathways Abolishes Vascular Remodeling and Experimental Pulmonary Hypertension.
    Ten Freyhaus H; Berghausen EM; Janssen W; Leuchs M; Zierden M; Murmann K; Klinke A; Vantler M; Caglayan E; Kramer T; Baldus S; Schermuly RT; Tallquist MD; Rosenkranz S
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1236-45. PubMed ID: 25745058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Associated with Heritable Pulmonary Arterial Hypertension Exert Convergent Actions on the miR-130/301-Vascular Matrix Feedback Loop.
    Bertero T; Handen AL; Chan SY
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30081553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension and insulin resistance: a mechanistic overview.
    Zanotto TM; Gonçalves AESS; Saad MJA
    Front Endocrinol (Lausanne); 2023; 14():1283233. PubMed ID: 38239990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.